NTRK1 and breast carcinoma: Triple-negative breast cancer (TNBC), accounting for 10%–20% of breast cancer, is characterized by the lack of estrogen receptor (ER), and progesterone receptor (PgR), and low expression of the receptor tyrosine kinase ErbB2 (also known as HER2/neu).